World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
50274
World Ranking
8764
National Ranking
4521

Akshay S. Desai publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Akshay S. Desai sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 397 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Akshay S. Desai D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Akshay S. Desai sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 98 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Akshay S. Desai is primarily affiliated with Brigham and Women's Hospital in the United States. Their research activity is focused extensively within the field of Medicine, with a particular concentration in Cardiology and Cardiovascular Medicine, which accounts for 437 of their publications. Other significant subfields include Endocrinology, Diabetes and Metabolism; Surgery; Pulmonary and Respiratory Medicine; and Epidemiology.

The scientist's work covers several main topics connected to cardiovascular and metabolic health. These include Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Diabetes Treatment and Management, Cardiac pacing and defibrillation studies, Pancreatic function and diabetes, Potassium and Related Disorders, and Hormonal Regulation and Hypertension.

Desai has contributed to numerous research articles published in major scientific journals. Frequent publication venues include the Journal of the American College of Cardiology, Circulation, European Heart Journal, JACC Heart Failure, and the European Journal of Heart Failure. These journals represent significant platforms in cardiovascular research, indicating the primary audience and academic communities engaged with their work.

Recent publications authored or coauthored by Akshay S. Desai demonstrate ongoing involvement in clinical and translational cardiovascular research. Notable papers include:

  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (2022), published in the New England Journal of Medicine
  • SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials (2022), published in The Lancet
  • Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes (2020), published in JAMA
  • Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial (2021), published in The Lancet
  • Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction (2020), published in Circulation

Collaboration is a significant aspect of Desai's research practice. Frequent co-authors include John J.V. McMurray, Scott D. Solomon, Pardeep S. Jhund, Brian Claggett, and Muthiah Vaduganathan. This network highlights multidisciplinary partnerships within cardiovascular and metabolic research communities.

Best Publications

  • Angiotensin-neprilysin inhibition versus enalapril in heart failure.

    John J. V. McMurray;Milton Packer;Akshay S. Desai;Jianjian Gong

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • Spironolactone for Heart Failure with Preserved Ejection Fraction

    Bertram Pitt;Marc A. Pfeffer;Susan F. Assmann;Robin Boineau

  • Strategies for Multivessel Revascularization in Patients with Diabetes

    Michael E. Farkouh;Michael Domanski;Lynn A. Sleeper;Flora S. Siami

  • Angiotensin-Neprilysin inhibition in heart failure with preserved ejection fraction

    Scott D. Solomon;John J.V. McMurray;Inder S. Anand;Junbo Ge

  • Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

    Hans-Henrik Parving;Hans-Henrik Parving;Barry M. Brenner;John J.V. McMurray;Dick de Zeeuw

  • Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

    Marc A. Pfeffer;Brian Claggett;Susan F. Assmann;Robin Boineau

  • Rehospitalization for Heart Failure: Predict or Prevent?

    Akshay S. Desai;Lynne W. Stevenson

  • 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

    Karen A. Hicks;Kenneth W. Mahaffey;Roxana Mehran;Steven E. Nissen

  • Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

    Milton Packer;John J. V. McMurray;Akshay S. Desai;Jianjian Gong

  • Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure

    Karl Swedberg;James B. Young;Inder S. Anand;Sunfa Cheng

  • Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy. A meta-analysis of randomized controlled trials

    A.S. Desai;J.C. Fang;W.H. Maisel;K.L. Baughman

  • Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.

    Eri T. Kato;Michael G. Silverman;Ofri Mosenzon;Thomas A. Zelniker

  • Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction

    Scott D. Solomon;Brian Claggett;Eldrin F. Lewis;Akshay Desai

  • Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin- converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)

    John J. V. McMurray;Milton Packer;Akshay S. Desai;Jim Gong

  • Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial

    Barry Greenberg;Javed Butler;G Michael Felker;Piotr Ponikowski

  • Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update

    Shannon M. Dunlay;Michael M. Givertz;David Aguilar;Larry A. Allen

  • Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction

    Viviany R Taqueti;Scott D Solomon;Amil M Shah;Akshay S Desai

  • Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients

    Akshay S. Desai;John J. V. McMurray;Milton Packer;Karl Swedberg

  • Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes

    Mark C Petrie;Subodh Verma;Kieran F Docherty;Silvio E Inzucchi

Frequent Co-Authors

Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
John J.V. McMurray
John J.V. McMurray University of Glasgow
Brian Claggett
Brian Claggett Brigham and Women's Hospital
Marc A. Pfeffer
Marc A. Pfeffer Harvard Medical School
Karl Swedberg
Karl Swedberg University of Gothenburg
Michael R. Zile
Michael R. Zile Medical University of South Carolina
Eldrin F. Lewis
Eldrin F. Lewis Stanford University
Inder S. Anand
Inder S. Anand University of Minnesota
Milton Packer
Milton Packer Baylor University Medical Center
Pardeep S. Jhund
Pardeep S. Jhund University of Glasgow

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering a career in healthcare, the USA offers flexible online pathways that can expand your options beyond traditional medical degrees. If you're eager to join the workforce quickly, lpn online programs allow you to train as a Licensed Practical Nurse in less time, offering a direct entry into patient care.

Mental health care is also a rapidly growing field. The pmhnp online programs provide fast-track routes to becoming a Psychiatric Mental Health Nurse Practitioner, a role in high demand across the country.

For those interested in leadership or administration, pursuing a online master of health administration can prepare you for executive and managerial positions in hospitals, clinics, and health systems.

Cost is often a concern for graduate study. Fortunately, universities now offer some of the most affordable mha programs to help you advance your healthcare career without overwhelming debt.

Online healthcare degrees are designed for flexibility, allowing you to balance study with personal and professional commitments while opening doors to a variety of rewarding roles in the medical field.

Best Scientists Citing Akshay S. Desai

Trending Scientists

Recently Published Articles